Polypharmacy as Evidence of Complex Injury in PI Cases

James Wong — Founder & CEO, LienScripts | March 26, 2026 | 8 min read

When a PI patient takes multiple simultaneous medications — polypharmacy — it documents multi-system injury that requires coordinated pharmaceutical intervention. Far from suggesting over-treatment, polypharmacy is clinical evidence that the accident caused complex, severe injuries affecting multiple body systems.

Polypharmacy as Evidence of Complex Injury in PI Cases

Polypharmacy — the concurrent use of multiple medications — in personal injury patients is clinical evidence that the accident caused injuries to multiple body systems, each requiring its own pharmacological treatment. A patient taking five medications is not being over-treated; they have five distinct injury components that a single medication cannot address.

• Each medication on the regimen targets a specific injury mechanism (inflammation, nerve pain, muscle spasm, sleep disruption, anxiety)
• Polypharmacy requires active physician management, including drug interaction monitoring
• The number of medications correlates with injury complexity, which supports higher settlement values
• Drug-drug interaction management itself is a clinical service that documents injury severity
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages

What Polypharmacy Tells Adjusters About Injury Severity

A single medication treats a single problem. Multiple medications treat multiple problems. When a PI patient takes gabapentin (nerve pain), meloxicam (inflammation), cyclobenzaprine (muscle spasm), zolpidem (insomnia), and buspirone (anxiety), the medication list itself is a diagnostic summary documenting five distinct injury consequences.

[!KEY] Every medication on a PI patient's regimen was independently prescribed by a licensed physician who determined that the specific condition required pharmacological treatment. Polypharmacy is the cumulative result of multiple independent clinical decisions — not a single billing-motivated prescription.

According to James Wong, PharmD, founder of LienScripts, "When we prepare a MERIT report for a patient on six medications, we document the clinical rationale for each one individually and then explain how they work together as a coordinated treatment regimen. The report shows the adjuster that this isn't random prescribing — it's systematic treatment of a complex injury."

The Anatomy of a Typical PI Polypharmacy Regimen

A moderately severe PI injury — such as a motor vehicle accident with disc herniation, cervical whiplash, and soft tissue injuries — commonly produces a regimen of 4-7 concurrent medications:

Anti-inflammatory (NSAID): Meloxicam 15mg daily

• Targets: Joint and soft tissue inflammation
• Documents: Ongoing inflammatory injury

Neuropathic pain agent: Gabapentin 600mg three times daily

• Targets: Nerve compression pain from disc herniation
• Documents: Neurological injury component

Muscle relaxant: Cyclobenzaprine 10mg at bedtime

• Targets: Muscle spasm from structural injury
• Documents: Musculoskeletal injury with ongoing spasm

Sleep medication: Zolpidem 10mg at bedtime

• Targets: Pain-related insomnia
• Documents: Functional impairment (inability to sleep)

GI protectant: Omeprazole 20mg daily

• Targets: Gastric protection from chronic NSAID use
• Documents: Treatment complexity requiring protective co-medication

Anti-anxiety: Buspirone 10mg twice daily

• Targets: Post-traumatic anxiety
• Documents: Psychological injury component

[!TIP] When presenting polypharmacy in a demand package, organize medications by the injury component they treat rather than listing them alphabetically. This organization makes it visually clear that each medication addresses a distinct injury — not that the patient is simply taking "a lot of pills."

Why the "Over-Treatment" Argument Fails

Insurance adjusters and defense attorneys sometimes argue that multiple medications indicate over-treatment or billing maximization. This argument fails on clinical and logical grounds.

Clinical reality: Personal injury accidents injure multiple biological systems simultaneously. A car accident that herniates a disc also inflames surrounding tissue, spasms muscles, disrupts sleep, and causes anxiety. No single medication addresses all of these systems. Each requires a drug that works through a different mechanism.

Physician independence: Each medication was prescribed by a licensed physician exercising independent clinical judgment. The pharmacy does not prescribe medications — it fills prescriptions written by treating physicians. Suggesting that the pharmacy "padded" the lien by dispensing prescribed medications misunderstands the healthcare delivery chain.

Standard of care: Multimodal pain management — using multiple medications from different drug classes — is the established standard of care for complex pain. The American Pain Society, the American Academy of Pain Medicine, and virtually every pain management guideline recommends multimodal therapy over single-drug approaches.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The adjusters who challenge polypharmacy are inadvertently arguing that the patient's injuries are so complex that they require five different medications. That's exactly the point — the injury is complex, and the medication regimen proves it."

Drug Interaction Monitoring: Additional Evidence of Complexity

Polypharmacy requires active clinical management to prevent harmful drug interactions. This management itself is evidence of injury complexity.

Common interactions in PI regimens:

• NSAIDs + GI protectants: The need for omeprazole with meloxicam documents that the anti-inflammatory treatment is long-term enough to require gastric protection
• Gabapentin + sleep medications: Both cause sedation; concurrent use requires careful dose titration
• Multiple CNS depressants: Combinations of gabapentin, muscle relaxants, and sleep medications require monitoring to avoid excessive sedation

What this proves: A patient whose medication regimen requires active interaction monitoring is, by definition, a complex patient with complex injuries. The monitoring itself is clinical evidence of severity.

[!KEY] The need for drug interaction monitoring and protective co-medications (like GI protectants with NSAIDs) is additional evidence of injury complexity. These "supportive" medications are not padding — they are clinically necessary consequences of treating severe, multi-system injury.

Quantifying Polypharmacy's Impact on Settlement Value

Polypharmacy affects settlement valuation in several ways:

1. Direct medication cost: More medications mean higher pharmacy lien amounts, directly increasing the documented damages.
2. Implied injury complexity: The number and variety of medications imply multi-system injury that justifies higher general damages.
3. Treatment burden documentation: Taking 5-7 medications daily is itself a quality-of-life impact — pill burden, side effects, and the constant reminder of injury.
4. Future treatment projection: A complex current regimen suggests ongoing future medication needs that may continue for years.
5. Side effect documentation: Each medication carries side effects that compound across the regimen — drowsiness, cognitive slowing, GI effects, weight changes — all impacting quality of life.

Presenting Polypharmacy in the Demand Package

Structure the polypharmacy section of the demand package as follows:

1. Body system inventory: List each injured body system and the corresponding medication
2. MERIT clinical narrative: For each medication, include the pharmacist-authored explanation of clinical necessity
3. Interaction management notes: Document the clinical complexity of managing the regimen
4. Quality-of-life impact: Describe the daily treatment burden — number of pills, dosing schedule, side effects
5. Future medication needs: Project ongoing treatment requirements based on current regimen stability

LienScripts MERIT documentation provides all of these elements in a single, pharmacist-signed report.

Contact LienScripts to learn how MERIT documentation presents polypharmacy evidence in your demand packages.

Related Resources

• How Medication History Proves Injury Severity
• Prescription Timeline as Causation Evidence
• Combination Drug Therapy in Personal Injury